These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3917587)

  • 1. The genetics of bone marrow transplantation in the rat.
    Oaks MK; Cramer DV
    Transplantation; 1985 Jan; 39(1):69-76. PubMed ID: 3917587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative roles of MHC and non-MHC antigens in bone marrow transplantation in rats. Graft acceptance and antigenic expression on donor red blood cells.
    Pinto M; Gill TJ; Kunz HW; Dixon-McCarthy BD
    Transplantation; 1983 Jun; 35(6):607-11. PubMed ID: 6346598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of classical (RT1.A) and nonclassical (RT1.C) MHC class I regions in natural killer cell-mediated bone marrow allograft rejection in rats.
    Engh E; Benestad HB; Strøm-Gundersen I; Vaage JT; Bell EB; Rolstad B
    Transplantation; 1998 Feb; 65(3):319-24. PubMed ID: 9484746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of allochimeric proteins to mitigate graft-versus-host and host-versus-graft immune responses to rat small bowel allografts.
    Okamoto M; Stepkowski SM; Wang M; Kahan BD
    Transplantation; 2000 Oct; 70(7):1060-7. PubMed ID: 11045643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation in miniature swine. II. Effect of selective genetic differences on marrow engraftment and recipient survival.
    Popitz-Bergez FA; Sakamoto K; Pennington LR; Pescovitz MD; McDonough MA; MacVittie TJ; Gress RE; Sachs DH
    Transplantation; 1988 Jan; 45(1):27-31. PubMed ID: 3122386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic graft-versus-host disease in rats after syngeneic bone marrow transplantation.
    Oaks MK; Cramer DV
    Transplantation; 1985 May; 39(5):504-10. PubMed ID: 3158105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
    Martin PJ
    J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
    Clerici M; Villa ML; Clerici E
    Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
    Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of graft failure by cyclosporine in rats receiving lymphocyte-depleted MHC-mismatched bone marrow.
    Wagner JE
    Transplantation; 1992 Mar; 53(3):624-8. PubMed ID: 1549856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of alphabeta- and gammadelta-T cells in allogenic donor marrow on engraftment, chimerism, and graft-versus-host disease.
    Huang Y; Cramer DE; Ray MB; Chilton PM; Que X; Ildstad ST
    Transplantation; 2001 Dec; 72(12):1907-14. PubMed ID: 11773887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-species graft-versus-host-disease is accompanied by a donor-derived cellular immune response.
    Cooper MH; Nalesnik MA; Watkins SC; Hoffman RA; Ildstad ST
    Transplantation; 1993 Oct; 56(4):934-40. PubMed ID: 8212220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of RT1.C-encoded MHC antigens on host-versus-graft and graft versus-host reactions in a model of small bowel transplantation in the rat.
    Fändrich F; Zhu X; Dresske B; Papachrysanthou A; Exner B; Chambers WH
    Transplant Proc; 1997 May; 29(3):1730-1. PubMed ID: 9142251
    [No Abstract]   [Full Text] [Related]  

  • 20. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.